Non-Small-Cell Lung Carcinoma (NSCLC)

Non-small-cell lung carcinoma (NSCLC) accounts for approximately 80 to 85% of lung cancers. The major subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. These subtypes, which arise from different types of lung cells, are grouped together as NSCLC because their treatment and prognosis are often similar. The main risk factors are smoking or exposure to secondhand smoke, exposure to asbestos, exposure to various types of radiation, or a family history of lung cancer.

Showing 1–12 of 42 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
03/2019
451,80 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2019
451,80 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
yes
2 mg
-80°C
04/2022
564,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
11/2022
451,80 
view product
Max: 2
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
04/2024
502,00 
view product
Max: 10
Min: 1
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
03/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
06/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
08/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
01/2019
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
12/2019
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
06/2020
182,70 
view product
Max: 8
Min: 2
Step: 1
1 2

Not looking for Non-Small-Cell Lung Carcinoma (NSCLC)?

Search our therapeutic molecules product database